| BOC Sciences | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (631) 485-4226 | |||
![]() |
info@bocsci.com | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2010 | ||||
| Selleck Chemicals LLC | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (713) 535-9129 | |||
![]() |
info@selleckchem.com | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2014 | ||||
| Amadis Chemical Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (571) 8992-5085 | |||
![]() |
sales@amadischem.com | |||
| Chemical manufacturer since 2010 | ||||
| chemBlink standard supplier since 2015 | ||||
| Enzo Life Sciences International Inc. | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (610) 941-0430 | |||
![]() |
info-usa@enzolifesciences.com | |||
| Chemical manufacturer | ||||
| Paragos e. K. | Germany | Inquire | ||
|---|---|---|---|---|
![]() |
+49 (2330) 807-9751 | |||
![]() |
sales@paragos.de | |||
| Chemical manufacturer since 2001 | ||||
| Santa Cruz Biotechnology, Inc. | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (831) 457-3800 | |||
![]() |
scbt@scbt.com | |||
| Chemical manufacturer | ||||
| Cayman Chemical Company | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (734) 971-3335 | |||
![]() |
sales@caymanchem.com | |||
| Chemical manufacturer | ||||
| VDM Biochemicals | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (330) 252-8181 | |||
![]() |
sales@vdmbio.com info@vdmbio.com | |||
| Chemical manufacturer | ||||
| Classification | Biochemical >> Inhibitor >> PI3K/Akt/mTOR inhibitor (PI3K/Akt/mTOR) >> GSK-3 inhibitor |
|---|---|
| Name | (2'Z,3'E)-6-Bromoindirubin-3'-oxime |
| Molecular Structure | ![]() |
| Molecular Formula | C16H10BrN3O2 |
| Molecular Weight | 356.17 |
| CAS Registry Number | 667463-62-9 |
| EC Number | 636-292-7 |
| Hazard Symbols |
Xi Details | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Risk Codes | R36/37/38 Details | ||||||||||||||||||||
| Safety Description | S26;S36 Details | ||||||||||||||||||||
| Hazard Classification | |||||||||||||||||||||
| |||||||||||||||||||||
| SDS | Available | ||||||||||||||||||||
| Market Analysis Reports |
| List of Reports Available for (2'Z,3'E)-6-Bromoindirubin-3'-oxime |